Package 13668-539-30

{"route": ["ORAL"], "spl_id": "3b2943e4-21ea-828b-e063-6294a90a275b", "openfda": {"upc": ["0313668540307", "0313668539301", "0313668538304", "0313668541304"], "unii": ["BEA68ZVB2K"], "rxcui": ["1482507", "1482515", "1482521", "1482525"], "spl_set_id": ["d279e461-2611-4f5c-938d-5d117612894f"], "manufacturer_name": ["Torrent Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET in 1 BOTTLE (13668-539-05)", "package_ndc": "13668-539-05", "marketing_start_date": "20250506"}, {"sample": false, "description": "30 TABLET in 1 BOTTLE (13668-539-30)", "package_ndc": "13668-539-30", "marketing_start_date": "20250506"}, {"sample": false, "description": "60 TABLET in 1 BOTTLE (13668-539-60)", "package_ndc": "13668-539-60", "marketing_start_date": "20250506"}], "brand_name": "Eslicarbazepine acetate", "product_id": "13668-539_3b2943e4-21ea-828b-e063-6294a90a275b", "dosage_form": "TABLET", "pharm_class": ["Cytochrome P450 2C19 Inhibitors [MoA]", "Cytochrome P450 3A4 Inducers [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "13668-539", "generic_name": "Eslicarbazepine acetate", "labeler_name": "Torrent Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Eslicarbazepine acetate", "active_ingredients": [{"name": "ESLICARBAZEPINE ACETATE", "strength": "400 mg/1"}], "application_number": "ANDA211227", "marketing_category": "ANDA", "marketing_start_date": "20250506", "listing_expiration_date": "20261231"}